who invented glp-1 drugs History of glucagon-like peptide-1 receptor agonists History of glucagon-like peptide-1 receptor

The present study was designed to assess GLP-1-induced diuresis and natriuresis in rats with HF and its interactions with renal nerve activity

Discover the benefits, mechanisms, and latest applications of GLP-1 receptor agonists in diabetes and obesity treatment.

A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial.

Papers: Langer Sawicka-Gutaj Batsis Heymsfield | 24 comments on LinkedIn

Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials

The GLP-1 receptor agonist market is projected to grow from $63.24 billion in 2026 to $161.40 billion by 2034, at a CAGR of 12.43% during the forecast period 20262034.